The pegylated arginine deiminase degrades arginine, creating arginine deficiency in ASS1-deficient cells and thereby inhibiting cancer cell growth, as demonstrated in melanoma and hepatocellular carcinoma cells in vitro [11]. This evidence concerns the gene ASS1 and hepatocellular carcinoma.